Transient Ischemic AttackLitterAITNCT07040761
Medical Literacy in TIA (Transient Ischemic Attack) Patients
An observational study of Transient Ischemic Attack, run by Hospices Civils de Lyon at 1 site in France.
Trial summary
There are around 30,000 TIAs (transient ischemic attacks) per year in France. This pathology can be the warning sign of a stroke, responsible for significant morbidity and mortality at the population level. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Transient Ischemic Attack
- What is being tested?
- Two medical questionnaires
- How many people
- 100 participants
- Where
- 1 siteFrance
- Study dates
- 30 Jun 2025to 5 Dec 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients from the Lyon region who consulted an emergency department with a final diagnosis of TIA, and sent to the neurology day hospital of Pierre Wertheimer neurological hospital
Who may be able to join
- Adult men and women ≥18 years old
- Patient referred to neurology day hospital at the Pierre Wertheimer neurological hospital after first care in the emergency department
- Patient having been informed and having expressed his non-opposition
- Patient affiliate to a social security scheme
Who cannot join
- Patient unable to complete the questionnaire
- History of stroke/TIA
- Patient who do not understand the French language
- Patient under legal protection, guardianship, curatorship, under judicial protection-
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluation of Medical Literacy in Patients Who Presented With a TIA Treated in Emergency Departments in Lyon
There are around 30,000 TIAs (transient ischemic attacks) per year in France. This pathology can be the warning sign of a stroke, responsible for significant morbidity and mortality at the population level.
An important part of patient care is to teach them to recognize the symptoms suggestive of a stroke as well as the contributing factors, thus improving the medical literacy of patients.
Read more
The results of studies that have assessed medical literacy in France and Europe converge towards a rather low level.
Some studies have focused on stroke literacy in France. They show good knowledge of risk factors and the attitude to adopt in the event of a stroke, but recognition of symptoms remains problematic.
There is very little literature concerning knowledge of TIA in the general population and there are no studies concerning literacy in a population having presented with TIA.
The aim of this study is to evaluate the knowledge of patients who have presented with a TIA (and therefore at high cardiovascular risk) about this disease (risk factors, symptoms, severity, attitude to adopt in the event of symptoms), after their visit to the emergency room.
The investigators make the hypothesis that knowledge of TIA and its consequences will be rather low in this population of patient, even after a medical contact at the emergency room.
- Conditions
- Transient Ischemic Attack
- Being tested
- Two medical questionnaires
- Keywords
- Transient ischemic attack, Medical literacy, Emergency department
- Medical subject headings
- Ischemic Attack, Transient, Emergencies
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Two medical questionnairesOther
Medical questionnaires delivered by hand and completed the same day
| Study group | Role | What they receive |
|---|---|---|
| TIA | TIA patients diagnosed in the emergency department and sent to neurology day hospital for evaluation Receives: Other: Two medical questionnaires |
What is being measured
The primary outcome is the main question the study is designed to answer.
Quality of responses to the medical literacy questionnaire specific to TIAs
The questionnaire contains 18 questions, open or closed. Each question will be analysed separately and the results will be expressed as a percentage of correct answer (in the case of a closed question mainly) or by specifying the different answers provided by the patients (in the case of an open question mainly)
Measured: Day 1 at inclusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jun 2025
- Study start30 Jun 2025
- Primary completion5 Dec 2025
- Study completion5 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Transient Ischemic AttackStudies of the same condition, open and under way.
- More trials run by Hospices Civils de LyonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospices Civils de Lyon
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Mathis Labeylie, DR, Principal investigator, Hospices Civils de Lyon
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07040761
- Sponsor's protocol ID
- 69HCL25_0091
- Other IDs
- 2025-A00239-40
- Acronym
- LitterAIT
- Status last verified
- Dec 2025
- First submitted
- 18 Jun 2025
- Last updated
- 19 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Medical Literacy in Patients Who Presented With a TIA Treated in Emergency Departments in Lyon
- ClinicalTrials.gov ID
- NCT07040761
- Acronym / sponsor ID
- LitterAIT / 69HCL25_0091
- Conditions
- Transient Ischemic Attack
- Keywords
- Transient ischemic attack, Medical literacy, Emergency department
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- Hospices Civils de LyonUniversity, hospital or other
- Study start
- 30 Jun 2025 (actual)
- Primary completion
- 5 Dec 2025 (actual)
- Study completion
- 5 Dec 2025 (actual)
- First posted
- 27 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
There are around 30,000 TIAs (transient ischemic attacks) per year in France. This pathology can be the warning sign of a stroke, responsible for significant morbidity and mortality at the population level.
An important part of patient care is to teach them to recognize the symptoms suggestive of a stroke as well as the contributing factors, thus improving the medical literacy of patients.
The results of studies that have assessed medical literacy in France and Europe converge towards a rather low level.
Some studies have focused on stroke literacy in France. They show good knowledge of risk factors and the attitude to adopt in the event of a stroke, but recognition of symptoms remains problematic.
There is very little literature concerning knowledge of TIA in the general population and there are no studies concerning literacy in a population having presented with TIA.
The aim of this study is to evaluate the knowledge of patients who have presented with a TIA (and therefore at high cardiovascular risk) about this disease (risk factors, symptoms, severity, attitude to adopt in the event of symptoms), after their visit to the emergency room.
The investigators make the hypothesis that knowledge of TIA and its consequences will be rather low in this population of patient, even after a medical contact at the emergency room.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| TIA | – | Other: Two medical questionnairesTIA patients diagnosed in the emergency department and sent to neurology day hospital for evaluation |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients from the Lyon region who consulted an emergency department with a final diagnosis of TIA, and sent to the neurology day hospital of Pierre Wertheimer neurological hospital
Key inclusion criteria (4 listed)
- Adult men and women ≥18 years old
- Patient referred to neurology day hospital at the Pierre Wertheimer neurological hospital after first care in the emergency department
- Patient having been informed and having expressed his non-opposition
- Patient affiliate to a social security scheme
Key exclusion criteria (4 listed)
- Patient unable to complete the questionnaire
- History of stroke/TIA
- Patient who do not understand the French language
- Patient under legal protection, guardianship, curatorship, under judicial protection-
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Two medical questionnairesMedical questionnaires delivered by hand and completed the same day | Other | TIA |
Primary outcome
Quality of responses to the medical literacy questionnaire specific to TIAs
Time frame: Day 1 at inclusion
The questionnaire contains 18 questions, open or closed. Each question will be analysed separately and the results will be expressed as a percentage of correct answer (in the case of a closed question mainly) or by specifying the different answers provided by the patients (in the case of an open question mainly)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Dec 2025.
- Individual participant dataSharing planned: No
Related trials for Transient Ischemic Attack
Active, not recruitingObservational study
Symptomatic Carotid Outcomes Registry
Carotid Stenosis, Ischemic Stroke
Not yet recruitingObservational study
Integrating Wearable Monitoring and Clinical Data for Stroke Early Warning
Stroke, Ischemic Stroke
Not yet recruitingObservational study
PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite)
Carotid Atherosclerosis, Carotid Artery Stenosis Asymptomatic
Not yet recruitingPhase 3
Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
Ischemia Stroke, TIA (Transient Ischemic Attack)
Recruiting
Understanding and Enhancing Human Health and Movement
Spinal Cord Injury, Stroke (CVA) or Transient Ischemic Attack
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mathis Labeylie, DR principal investigator
Hospices Civils de Lyon
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Transient Ischemic Attack, run by Hospices Civils de Lyon at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Quality of responses to the medical literacy questionnaire specific to TIAs (time frame: Day 1 at inclusion). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2025.